ROCHESTER, MN – A groundbreaking artificial intelligence (AI) model, developed by the Mayo Clinic, has demonstrated the ability to detect pancreatic cancer on routine abdominal CT scans up to three years before traditional diagnosis. The system, known as the Radiomics-based Early Detection Model (REDMOD), identified 73% of prediagnostic cancers at a median of 16 months prior to clinical detection, nearly doubling the rate achieved by specialists without AI assistance. This significant advancement addresses a critical challenge in treating one of the deadliest cancers, which often goes undetected until advanced stages.
The REDMOD system works by analyzing subtle tissue texture and structural changes in CT scans that are often imperceptible to the human eye. This allows for the identification of early biological signals of cancer development, particularly in high-risk patients such as those with new-onset diabetes. Mayo Clinic radiologist and nuclear medicine specialist Dr. Ajit Goenka, senior author of the study published in the journal Gut, stated, "The greatest barrier to saving lives from pancreatic cancer has been our inability to see the disease when it is still curable." He added that this AI "can now identify the signature of cancer from a normal-appearing pancreas and it can do so reliably over time and across diverse clinical settings."
Pancreatic cancer is notoriously difficult to diagnose early due to its hidden location and often vague or absent initial symptoms. More than 85% of patients receive a diagnosis after the disease has already spread, contributing to a five-year survival rate below 15%. This new AI tool offers a potential paradigm shift, enabling earlier intervention when curative treatments are still possible. Researchers are now advancing this work into clinical testing through the AI-PACED study, evaluating its integration into patient care.
While the life-saving potential of such AI tools is evident, the broader integration of AI in healthcare continues to spark discussion. As Katherine Brodsky noted in a recent tweet, "I have many concerns about AI too, but that's quite an odd reaction specifically over news that an AI model will be able to do early detection of pancreatic cancer and save lives." Ethical considerations surrounding AI in medical diagnostics often include data privacy, potential algorithmic bias, accountability for errors, and maintaining human empathy in patient care. Experts emphasize the need for robust regulatory frameworks and diverse training data to ensure equitable and safe deployment of these powerful technologies.
